68
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Utilization of Preventive Health Services by HIV-Seronegative Injection Drug Users

, , &
Pages 93-102 | Published online: 12 Oct 2008

References

  • Stein , M D . 1990 . Medical complications of intravenous drug use . JGIM. , 5 : 249 – 57 .
  • Cherubin , C E and Sapira , J D . 1993 . The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later . Ann Intern Med. , 119 ( 10 ) : 1017 – 1027 .
  • Selwyn , P A and O'Connor , P G . 1992 . Diagnosis and treatment of substance users with HIV infection . Primary Care. , 19 ( 1 ) : 119 – 156 .
  • O'Connor , P G , Selwyn , P A and Schottenfeld , R S . 1994 . Medical care for injection-drug users with human immunodeficiency virus infection . N Engl J Med. , 331 ( 7 ) : 450 – 459 .
  • Baldwin , W A , Rosenfeld , B A , Breslow , M J , Buchman , T G , Deutschman , C S and Moore , R D . 1993 . Substance abuse-related admissions to adult intensive care . Chest. , 103 ( 1 ) : 21 – 25 .
  • Paone , D , Des Jarlais , D , Clark , J , Shi , Q and Krim , M . 1997 . Update: syringe-exchange programs-United States, 1996 . JAMA , 278 ( 3 ) : 197 – 198 .
  • Gostin , L O , Lazzarini , Z , Jones , T S and Flaherty , K . 1997 . Prevention of HIV/AIDS and other blood-borne diseases among injection drug users: A national survey on the regulation of syringes and needles . JAMA , 277 ( 1 ) : 53 – 62 .
  • Friedmann , P D , Alexander , J A , Jin , L and D'Aunno , T A . 2000 . Medical and psychosocial services in outpatient drug abuse treatment: do stronger linkages promote client utilization? . Health Services Research. , 35 ( 2 ) : 443 – 465 .
  • DiBisceglie , A M . 1998 . Hepatitis C . Lancet. , 351 ( 9099 ) : 351 – 355 .
  • Kelen , G D , Green , G B , Purcell , R H , Chan , D W , Oaqish , B F Sivertson , K T . 1992 . Hepatitis B and hepatitis C in emergency department patients . N Engl J Med. , 326 ( 21 ) : 1399 – 404 .
  • Zeldis , J B , Jain , S , Kuramoto , I K , Richards , C , Sazama , K Samuels , S . 1992 . Seroepidemiology of viral infections among intravenous drug users in northern California . Western J Med. , 156 ( 1 ) : 30 – 35 .
  • Kemp , R , Miller , J , Lungley , S and Baker , M . 1998 . Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations . New Zealand Med J. , 111 ( 1060 ) : 50 – 53 .
  • Haverkos , H W . 1991 . Infectious diseases and drug abuse: prevention and treatment in the drug abuse treatment system . J Substance Abuse Treatment. , 8 : 269 – 275 .
  • Garfein , R S , Vlahov , D Gacal , N . 1996 . Viral infections in short-term injection drug users: the prevalence of hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotrophic viruses . AM J Public Health. , 86 : 655 – 661 .
  • Gifford , A L , McPhee , S J and Fordham , D . 1994 . Preventive care among HIV-positive patients in a general medicine practice . Am J Prev Med. , 10 ( 1 ) : 5 – 9 .
  • Parrino , M W . 1993 . Center for substance abuse treatment. State methadone treatment guidelines , Treatment Improvement Protocol (TIP) series US Department of Health and Human Services .
  • Preventive U.S. Services Task Force . 1996 . Guide to clinical preventive services, , 2nd ed , Baltimore : Williams & Wilkins .
  • Selwyn , P A , Feingold , A R Hartel , D . 1988 . Increased risk of bacterial pneumonia in HIV-infected intravenous users without AIDS . AIDS. , 2 : 267 – 272 .
  • Rezza , G , Giuliani , M , Serraino , D , Branca , M , Benedetto , A , Garbuglia , A , Ippolito , G and Franceschi , S . 1998 . Risk factors for cervical presence of human papillomavirus DNA among women at risk for HIV infection. DIANAIDS Collaborative Study Group . Epidemiology & Infection. , 121 ( 1 ) : 173 – 177 .
  • Hayward , R A , Shapiro , M F , Freeman , H E and Corey , C R . 1988 . Who gets screened for cervical and breast cancer? Results from a new national survey . Arch Intern Med. , 148 ( 5 ) : 1177 – 1181 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.